RP

Rajen Panda

Active Director Director DIN 10285378
DIN 10285378 First appointment Aug 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Rajen Panda

Data last updated:

Rajen Panda is a Director at Ordell Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Ordell Pharmaceuticals Private Limited reported revenue of ₹10,000 (FY 2024).

DIN 10285378
Primary Designation Director
Industry Pharma
First Appointment 20 Aug 2023
Oldest Company Age 3 yrs
Largest company Ordell Pharmaceuticals Private Limited · ₹10,000 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Aug 20232023₹10,000 (FY 2024)Active

Board colleagues of Rajen Panda

NameDINCompanyDesignation
Pausali Banerji Panda10285379Ordell Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ordell Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajen Panda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajen Panda

Rajen Panda currently holds 1 directorship: Ordell Pharmaceuticals Private Limited (Director, since 20 Aug 2023, revenue ₹10,000 (FY 2024)).

Rajen Panda was first appointed on 20 Aug 2023 as Director at Ordell Pharmaceuticals Private Limited.

The current boards of Rajen Panda's companies include Pausali Banerji Panda (Ordell Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available